| __timestamp | Novavax, Inc. | Pfizer Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 79435000 | 8393000000 |
| Thursday, January 1, 2015 | 162644000 | 7690000000 |
| Friday, January 1, 2016 | 237939000 | 7872000000 |
| Sunday, January 1, 2017 | 168435000 | 7657000000 |
| Monday, January 1, 2018 | 173797000 | 8006000000 |
| Tuesday, January 1, 2019 | 113842000 | 8650000000 |
| Wednesday, January 1, 2020 | 747027000 | 9405000000 |
| Friday, January 1, 2021 | 2534508000 | 13829000000 |
| Saturday, January 1, 2022 | 1235278000 | 11428000000 |
| Sunday, January 1, 2023 | 737502000 | 10679000000 |
| Monday, January 1, 2024 | 10930000000 |
Igniting the spark of knowledge
In the ever-evolving world of biotechnology, research and development (R&D) is the lifeblood of innovation. Over the past decade, Pfizer Inc. and Novavax, Inc. have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, Pfizer consistently allocated substantial funds, peaking in 2021 with a 38% increase from 2014. This commitment underscores Pfizer's robust pipeline and its strategic focus on groundbreaking therapies.
Conversely, Novavax's R&D spending surged dramatically in 2021, marking a 3,100% increase from 2014, driven by its pivotal role in COVID-19 vaccine development. However, by 2023, their spending had decreased by 71% from the 2021 peak, reflecting a shift in focus post-pandemic. This dynamic landscape highlights the critical role of R&D in shaping the future of healthcare, with each company's strategy reflecting its unique market position and innovation goals.
Research and Development: Comparing Key Metrics for Johnson & Johnson and Novavax, Inc.
Research and Development Expenses Breakdown: AbbVie Inc. vs Pfizer Inc.
Research and Development Investment: AstraZeneca PLC vs Novavax, Inc.
Research and Development Expenses Breakdown: Pfizer Inc. vs GSK plc
Research and Development Expenses Breakdown: Pfizer Inc. vs Ascendis Pharma A/S
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Amicus Therapeutics, Inc.
Research and Development Expenses Breakdown: Pfizer Inc. vs HUTCHMED (China) Limited
Analyzing R&D Budgets: Pfizer Inc. vs BioCryst Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Neurocrine Biosciences, Inc. and Novavax, Inc.
Research and Development Investment: Axsome Therapeutics, Inc. vs Novavax, Inc.
Research and Development Investment: Perrigo Company plc vs Novavax, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Arrowhead Pharmaceuticals, Inc. and Novavax, Inc.